From: Glioma SOX2 expression decreased after adjuvant therapy
Variable | Overall survival | Progression-free survival | ||
---|---|---|---|---|
HR(95% CI) | P | HR(95% CI) | P | |
Age | 1.060 | 0.08 | 1.000 | 1.000 |
Sex | 0.641 | 0.438 | 3.070 | 0.122 |
Adjuvant therapy after first surgery | 1.121 | 0.852 | 1.459 | 0.563 |
Resection type | 1.171 | 0.799 | 0.460 | 0.244 |
SOX2 | 0.215 | 0.076 | 0.160 | 0.045 |
WHO grade | 1.722 | 0.427 | 11.606 | 0.001 |
Type of recurrence | 2.301 | 0.377 | 1.166 | 0.866 |